A detailed history of Black Rock Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,231,058 shares of ATRC stock, worth $96.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,231,058
Previous 4,193,887 0.89%
Holding current value
$96.3 Million
Previous $150 Million 14.01%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$28.21 - $37.78 $1.05 Million - $1.4 Million
37,171 Added 0.89%
4,231,058 $129 Million
Q4 2023

Feb 13, 2024

BUY
$32.99 - $43.25 $7.76 Million - $10.2 Million
235,245 Added 5.94%
4,193,887 $150 Million
Q3 2023

Nov 13, 2023

BUY
$41.12 - $57.73 $1.8 Million - $2.53 Million
43,850 Added 1.12%
3,958,642 $173 Million
Q2 2023

Aug 11, 2023

BUY
$40.44 - $49.6 $2.37 Million - $2.9 Million
58,501 Added 1.52%
3,914,792 $193 Million
Q1 2023

May 12, 2023

BUY
$35.87 - $47.22 $4.32 Million - $5.69 Million
120,525 Added 3.23%
3,856,291 $160 Million
Q4 2022

Feb 13, 2023

BUY
$33.48 - $47.45 $5.1 Million - $7.22 Million
152,221 Added 4.25%
3,735,766 $166 Million
Q3 2022

Nov 14, 2022

SELL
$38.25 - $52.62 $1.51 Million - $2.08 Million
-39,496 Reduced 1.09%
3,583,545 $140 Million
Q2 2022

Aug 12, 2022

SELL
$35.1 - $66.01 $795,190 - $1.5 Million
-22,655 Reduced 0.62%
3,623,041 $148 Million
Q1 2022

May 12, 2022

SELL
$57.43 - $71.39 $3.96 Million - $4.93 Million
-68,995 Reduced 1.86%
3,645,696 $239 Million
Q4 2021

Feb 10, 2022

BUY
$63.4 - $87.14 $3.89 Million - $5.35 Million
61,430 Added 1.68%
3,714,691 $258 Million
Q3 2021

Nov 09, 2021

SELL
$69.28 - $84.46 $669,521 - $816,221
-9,664 Reduced 0.26%
3,653,261 $254 Million
Q2 2021

Aug 11, 2021

BUY
$64.13 - $80.18 $235 Million - $294 Million
3,662,925 New
3,662,925 $291 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.06B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.